TransMedics Group, Inc. (TMDX) Stock Overview
Explore TransMedics Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.
TransMedics Group, Inc. (TMDX)
Key Financials
Key Financials
Market Cap
2.6B
P/E Ratio
14.64
EPS (TTM)
$2.45
ROE
0.42%
TMDX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of TransMedics Group, Inc. (TMDX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $126.72.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.64 and a market capitalization of 2.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.